Versant Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 25
Professionals
  • Investments
  • 445
  • Portfolio
  • 57
  • Exits
  • 189
Exits

Versant Ventures General Information

Description

Founded in 1999, Versant Ventures is a venture capital firm that is based in San Francisco, California. The firm prefers to invest in the healthcare sector.

Contact Information

Year Founded
1999
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
  • One Sansome Street
  • Suite 3630
  • San Francisco, CA 94104
  • United States
+1 (415) 000-0000

Versant Ventures Investments (445)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Capsida Biotherapeutics 29-Apr-2021 Early Stage VC 0000 Biotechnology Startup 00000 00000 00.0
000000 00000000000 08-Apr-2021 00000 00000 00000 Drug Discovery Generating Revenue 00000 00000 00.0
0000000 0000000000 29-Mar-2021 0000 0000 Drug Discovery Generating Revenue 000000 0000000 00.0
00000 0000 0000000 21-Mar-2021 00000 00000 0000 Drug Discovery Generating Revenue 0000000 000000 00.0
00000000 000 11-Mar-2021 00000 00000 00000 Biotechnology Clinical Trials - General 00000 0000000 00.0
00000000 000000000 11-Feb-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 00000 00000 00.0
0000000 0000000000 01-Feb-2021 00000 00000 00000 Drug Discovery Generating Revenue 00000 0000000 00.0
00000000 000000000 01-Feb-2021 00000 00000 00000 Drug Discovery Generating Revenue 000000 0000000 00.0
Gritstone Oncology 28-Dec-2020 PIPE 00000 Biotechnology Generating Revenue/Not Profitable 000000 0000000 00.0
RayzeBio 30-Nov-2020 Early Stage VC 00000 Drug Discovery Startup 00000 00000 00.0
You’re viewing 10 of 445 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Versant Ventures Exits (189)

Company Name Exit Date Exit Type Exit Size
Respicardia 09-Apr-2021 Merger/Acquisition
000000000 09-Apr-2021 000 00000
0000 000000000000 25-Mar-2021 000 00000
0000000 000 22-Jan-2021 000000 0000000000 00000
00000000 0000000 16-Dec-2020 0000000000
000 15-Dec-2020 000000000000000000
000000 00000000000 16-Oct-2020 000 00000
0000000 0000000000 17-Jul-2020 000 00000
Akero Therapeutics 09-Jul-2020 Public Investment 2nd Offering 00000
Repare Therapeutics 19-Jun-2020 IPO 00000
You’re viewing 10 of 189 exits. Get the full list »

Versant Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Versant Ventures‘s full profile, request access.

Request a free trial

Versant Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Versant Ventures Team (64)

Name Title Deals Funds Boards Office
Robin Praeger Chief Financial Officer & Managing Director 0 San Francisco, CA
Barbara Lubash Co-Founder & Managing Director 00 0 0 San Francisco, CA
Donald Milder Co-Founder & Managing Director 0 0 0 San Francisco, CA
Rebecca Robertson Co-Founder & Managing Director 00 0 0 San Francisco, CA
Samuel Colella Co-Founder & Managing Director 00 0 0 San Francisco, CA
You’re viewing 5 of 64 team members. Get the full list »

Versant Ventures Co-Investors (182)

Name With Exits Lead Partner Series Industry
OrbiMed 10 0 0 Series chart Industry bar
RA Capital Management 0 0 0 Series chart Industry bar
Alexandria Venture Investments 0 0 0 Series chart Industry bar
Logos Capital 0 0 Series chart Industry bar
New Enterprise Associates 0 0 00 Series chart Industry bar
You’re viewing 5 of 182 co-investors. Get the full list »